Stay updated with breaking news from Nasdaq Amph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Free Report) is scheduled to be issuing its quarterly earnings data after the market closes on Wednesday, May 8th. Analysts expect the company to announce earnings of $0.73 per share for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link. […]
China Universal Asset Management Co. Ltd. increased its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 339.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,542 shares of the company’s stock after buying an additional 4,281 […]
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Free Report) Director Floyd F. Petersen sold 500 shares of the stock in a transaction on Monday, April 1st. The stock was sold at an average price of $43.43, for a total value of $21,715.00. Following the completion of the sale, the director now directly owns 79,333 shares in […]
Legato Capital Management LLC lifted its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 95.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,217 shares of the company’s stock after purchasing an additional 7,431 […]
Eagle Asset Management Inc. trimmed its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 45.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 37,701 shares of the company’s stock after selling 31,888 shares during the quarter. Eagle […]